NCT04246320View on ClinicalTrials.gov

Taking Brain Monitoring to the Next Level

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

August 13, 2022

Study Completion Date

August 13, 2022

Conditions
Postoperative Cognitive DysfunctionPostoperative DeliriumObstructive Sleep Apnea
Interventions
OTHER

Goal directed therapy (GDT)

Goal directed therapy (GDT) hemodynamic management (MAP \> 60 mmHg) and processed EEG-guided anesthesia (PSI targeted between 30-50).

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04246320 - Taking Brain Monitoring to the Next Level | Biotech Hunter | Biotech Hunter